Pub Date : 2019-01-23DOI: 10.32474/ADO.2019.01.000125
Pramod Stephen
Citation: Pramod Stephen. (2019). Bowels and Urine Odors and its Solutions. Archives of Endocrinology and Diabetes 1(1). From the beginning time people go for bowel outside in the fields and when he was doing bowel that time how much time he spend that place he must live in the environments of the bowel odor. And till now after many improvement of toilets we must live in odor of poop in our toilets .we use perfume detergent cake and any kind of chemicals to remove odor but odor mixed with perfume or chemical and disturb our nose to brain and our mood become distress. And when our brain gets disturb then our metabolic process is also disturb. Poop odor spread soon after and its cover near about 5 to 8 feet diameters within 30 second and by smell flies and other insects attack the night soil .because it is good food for them. By the odor of bowel we can get air born diseases and other diseases like hepatitis, e-coli, dysentery viral infection, cholera diarrhea etc same time our faces contain many kind of egg of worms and it is possible to get water born diseases. odor of bowel is very slow poison because it contain sulfur compound, hydrogen sulfide, l,, bilirubin, bilverdin, various salt, Harmons, carbohydrates, fatty acid nitrogen, phosphorus and un digested food particles these are same compound that are responsible for odor of flatulence.
{"title":"Bowels and Urine Odors and Its Solutions","authors":"Pramod Stephen","doi":"10.32474/ADO.2019.01.000125","DOIUrl":"https://doi.org/10.32474/ADO.2019.01.000125","url":null,"abstract":"Citation: Pramod Stephen. (2019). Bowels and Urine Odors and its Solutions. Archives of Endocrinology and Diabetes 1(1). From the beginning time people go for bowel outside in the fields and when he was doing bowel that time how much time he spend that place he must live in the environments of the bowel odor. And till now after many improvement of toilets we must live in odor of poop in our toilets .we use perfume detergent cake and any kind of chemicals to remove odor but odor mixed with perfume or chemical and disturb our nose to brain and our mood become distress. And when our brain gets disturb then our metabolic process is also disturb. Poop odor spread soon after and its cover near about 5 to 8 feet diameters within 30 second and by smell flies and other insects attack the night soil .because it is good food for them. By the odor of bowel we can get air born diseases and other diseases like hepatitis, e-coli, dysentery viral infection, cholera diarrhea etc same time our faces contain many kind of egg of worms and it is possible to get water born diseases. odor of bowel is very slow poison because it contain sulfur compound, hydrogen sulfide, l,, bilirubin, bilverdin, various salt, Harmons, carbohydrates, fatty acid nitrogen, phosphorus and un digested food particles these are same compound that are responsible for odor of flatulence.","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43125141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-12-19DOI: 10.32474/ADO.2018.01.000124
P. G. Raman
Patients with type-2 diabetes have more than half the day in the post meal state. Elevation in post meal plasma glucose is due to loss of first phase insulin secretion, decreased insulin sensitivity in peripheral tissues and consequent decreased suppression of hepatic glucose output after meals due to insulin deficiency. Elevated or exaggerated post meal response is directly responsible for endothelial dysfunction and pro-atherogenic states. Post-meal hyperglycemia is a prominent early defect in type-2 diabetes patients.
{"title":"Management of Postprandial Blood Glucose in Diabetes Mellitus","authors":"P. G. Raman","doi":"10.32474/ADO.2018.01.000124","DOIUrl":"https://doi.org/10.32474/ADO.2018.01.000124","url":null,"abstract":"Patients with type-2 diabetes have more than half the day in the post meal state. Elevation in post meal plasma glucose is due to loss of first phase insulin secretion, decreased insulin sensitivity in peripheral tissues and consequent decreased suppression of hepatic glucose output after meals due to insulin deficiency. Elevated or exaggerated post meal response is directly responsible for endothelial dysfunction and pro-atherogenic states. Post-meal hyperglycemia is a prominent early defect in type-2 diabetes patients.","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49053543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-11-26DOI: 10.32474/ADO.2018.01.000122
Lovoria B. Williams, S. Looney, A. Kriska
Since 2010, the American Diabetes Association has endorsed both HbA1C (A1C) and fasting plasma glucose (FPG) to determine diabetes risk. Given the discordance between classifications based on FPG and A1C and higher A1C levels among African Americans (AAs) than whites, we sought to examine the prevalence of normoglycemia, prediabetes, and diabetes among a community sample of adult AAs (n=704) screened for enrollment in a randomized Diabetes Prevention Program (DPP). We conducted a retrospective analysis to estimate the degree of discordance between risk categories based on FPG and A1C and examine the risk factors that predicted A1C and FPG levels. To determine differential effects on risk categories defined using FPG and A1C, we examined the effects of the program on the measures at 12 weeks post-intervention among the intervention arm participants.
{"title":"Differences in participant classification and intervention effects based on HbA1C and fasting plasma glucose among a community sample of African Americans","authors":"Lovoria B. Williams, S. Looney, A. Kriska","doi":"10.32474/ADO.2018.01.000122","DOIUrl":"https://doi.org/10.32474/ADO.2018.01.000122","url":null,"abstract":"Since 2010, the American Diabetes Association has endorsed both HbA1C (A1C) and fasting plasma glucose (FPG) to determine diabetes risk. Given the discordance between classifications based on FPG and A1C and higher A1C levels among African Americans (AAs) than whites, we sought to examine the prevalence of normoglycemia, prediabetes, and diabetes among a community sample of adult AAs (n=704) screened for enrollment in a randomized Diabetes Prevention Program (DPP). We conducted a retrospective analysis to estimate the degree of discordance between risk categories based on FPG and A1C and examine the risk factors that predicted A1C and FPG levels. To determine differential effects on risk categories defined using FPG and A1C, we examined the effects of the program on the measures at 12 weeks post-intervention among the intervention arm participants.","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44726002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-09-26DOI: 10.32474/ado.2018.01.000117
Rahul A Hajare
{"title":"Lack of Evidence for Window Cancer of Healthy Adults Attending Low Standards Pharmacy Institutions in Pune","authors":"Rahul A Hajare","doi":"10.32474/ado.2018.01.000117","DOIUrl":"https://doi.org/10.32474/ado.2018.01.000117","url":null,"abstract":"","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75152916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-09-24DOI: 10.32474/ado.2018.01.000116
J. Unger
Hypoglycemia is the rate-limiting step of intensive management in patients with diabetes. Lowering one’s A1C to a prescribed target is expected to mitigate one’s risk of developing longand short-term diabetes-related complications. Several of the less expensive and commonly prescribed glucose lowering agents favored by practitioners result in weight gain, hypoglycemia, and even an increased risk of cardiovascular (CV) mortality. Although achieving a targeted A1C of <7 % is the standard of care, clinicians often fail to evaluate patients for glycemic variability which can increase oxidative stress driving long-term diabetesrelated complications including CV death. The use of concentrated insulins and glucagon-like peptide-1 receptor agonists separately or in combination with each other reduces glycemic variability and one’s risk of hypoglycemia. Pharmaceutical agents which allow patients to safely achieve their targeted A1C without weight gain and hypoglycemia should be preferred in patients with type 2 diabetes.
{"title":"Management of Hypoglycemia in Patients with Type 2 Diabetes","authors":"J. Unger","doi":"10.32474/ado.2018.01.000116","DOIUrl":"https://doi.org/10.32474/ado.2018.01.000116","url":null,"abstract":"Hypoglycemia is the rate-limiting step of intensive management in patients with diabetes. Lowering one’s A1C to a prescribed target is expected to mitigate one’s risk of developing longand short-term diabetes-related complications. Several of the less expensive and commonly prescribed glucose lowering agents favored by practitioners result in weight gain, hypoglycemia, and even an increased risk of cardiovascular (CV) mortality. Although achieving a targeted A1C of <7 % is the standard of care, clinicians often fail to evaluate patients for glycemic variability which can increase oxidative stress driving long-term diabetesrelated complications including CV death. The use of concentrated insulins and glucagon-like peptide-1 receptor agonists separately or in combination with each other reduces glycemic variability and one’s risk of hypoglycemia. Pharmaceutical agents which allow patients to safely achieve their targeted A1C without weight gain and hypoglycemia should be preferred in patients with type 2 diabetes.","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69690798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-08-28DOI: 10.32474/ADO.2018.01.000113
G. Annunziata, M. Maisto, Connie Schisano, L. Barrea, R. Ciampaglia, Viviana Narciso, G. Tenore, E. Novellino
Among the cardiometabolic diseases, type 2 diabetes mellitus (T2DM) is one of the most diffused worldwide. Pharmacological treatments commonly used present several side effects, and this is driving people to search natural approaches. Olea europaea is currently investigated for its anti-diabetic potential. In particular, oleuropein (OLE), its main bioactive compound, have been demonstrated to exert interesting activities in management of T2DM, including hypoglycemic and antioxidant activities. The purpose of this manuscript is to review the available scientific evidence evaluating the role of OLE in managing T2DM.
{"title":"Oleuropein as a novel anti-diabetic nutraceutical. An overview","authors":"G. Annunziata, M. Maisto, Connie Schisano, L. Barrea, R. Ciampaglia, Viviana Narciso, G. Tenore, E. Novellino","doi":"10.32474/ADO.2018.01.000113","DOIUrl":"https://doi.org/10.32474/ADO.2018.01.000113","url":null,"abstract":"Among the cardiometabolic diseases, type 2 diabetes mellitus (T2DM) is one of the most diffused worldwide. Pharmacological treatments commonly used present several side effects, and this is driving people to search natural approaches. Olea europaea is currently investigated for its anti-diabetic potential. In particular, oleuropein (OLE), its main bioactive compound, have been demonstrated to exert interesting activities in management of T2DM, including hypoglycemic and antioxidant activities. The purpose of this manuscript is to review the available scientific evidence evaluating the role of OLE in managing T2DM.","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44058526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-27DOI: 10.32474/ado.2018.01.000111
N. Papanas
{"title":"Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes","authors":"N. Papanas","doi":"10.32474/ado.2018.01.000111","DOIUrl":"https://doi.org/10.32474/ado.2018.01.000111","url":null,"abstract":"","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45770226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-19DOI: 10.32474/ADO.2018.01.000109
G. Annunziata, G. Tenore, E. Novellino
It is well known that obesity and diabetes (more specifically, the type 2 diabetes mellitus, T2DM) are currently a growing public health problem, which involves several millions subjects in the World. Years ago, indeed, the term “diabesity” was coined highlighting not only the strong pathogenic relationship between obesity and T2DM, but also the pandemic aspect that link these two diseases. The increasing global prevalence of diabesity represents a grave concern in terms of public health and, at the same time, medical costs, resulting in a serious social economic issue.
{"title":"Resveratrol-based Nutraceuticals for the Management of Diabetes and Obesity: Real Therapeutic Potential or a mere Palliative?","authors":"G. Annunziata, G. Tenore, E. Novellino","doi":"10.32474/ADO.2018.01.000109","DOIUrl":"https://doi.org/10.32474/ADO.2018.01.000109","url":null,"abstract":"It is well known that obesity and diabetes (more specifically, the type 2 diabetes mellitus, T2DM) are currently a growing public health problem, which involves several millions subjects in the World. Years ago, indeed, the term “diabesity” was coined highlighting not only the strong pathogenic relationship between obesity and T2DM, but also the pandemic aspect that link these two diseases. The increasing global prevalence of diabesity represents a grave concern in terms of public health and, at the same time, medical costs, resulting in a serious social economic issue.","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44143551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-11DOI: 10.32474/ado.2018.01.000107
Rahul A Hajare
{"title":"Depression‐Level Effectiveness of the Curse Words in Young Adults in Pune University","authors":"Rahul A Hajare","doi":"10.32474/ado.2018.01.000107","DOIUrl":"https://doi.org/10.32474/ado.2018.01.000107","url":null,"abstract":"","PeriodicalId":93731,"journal":{"name":"Archives of diabetes & obesity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86500608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：